Key result
Right heart thrombi in patients with pulmonary embolism were associated with significantly higher 30-day pulmonary embolism-related mortality compared to matched controls (19% vs 8%, p=0.003).
Why the study?
Does the presence of right heart thrombi increase 30-day mortality in patients with pulmonary embolism?
Population
414 patients with pulmonary embolism, including 138 with right heart thrombi and 276 propensity-matched…
Comparison
Presence of right heart thrombi (RiHT) vs Propensity score-matched control group without…
Design
Cohort
Follow-up
30-day
Authors
Loading...
RiHT was associated with higher PE mortality; hypothesis-generating for risk stratification trials before practice change.
Cohort (n=414)
Yes
Does the presence of right heart thrombi increase 30-day mortality in patients with pulmonary embolism?
Absolute Event Rate: 19% vs 8%
p-value: p=0.003
Koć et al. (2016) conducted a cohort in Pulmonary embolism (n=414). Right heart thrombi vs. Patients without right heart thrombi was evaluated on 30-day pulmonary embolism-related mortality (p=0.003). Right heart thrombi in patients with pulmonary embolism were associated with significantly higher 30-day pulmonary embolism-related mortality compared to matched controls (19% vs 8%, p=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: